Japan STD diagnostics market is growing at a CAGR of around 8.8% during the forecast period. The high prevalence of syphilis among young women has encouraged the Japan health ministry to find ways of treating the STDs, which is likely to influence the growth of the Japan STD diagnostics market. According to hospital reports from across Japan, there were 4,259 syphilis cases in 2016-17, up from 77% from the 2,412 cases reported from the last year. Most of the cases are believed to be caused by unprotected coitus, however, cases of mother-to-child transmission, which is rare, are also on the rise. Japan government and healthcare ministry are encouraging citizens to get tested for STDs as the disease can be transmitted from one person to another. Thus, prevalence of such enhances the growth of the market during the forecast period
Visit for Global Sexually Transmitted Diseases (STD)
Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size
Further, some others factors affecting the growth of the Japan STD Diagnostics market includes changes in sexual behavior in the youth, as well as increasing number of tourists coming from countries which may results in some infection rates are often referred as factors causing STDs. However, the true cause of syphilis’ rapid spread over the past decade remains unclear. While screening patients for syphilis, the doctors ask whether they have recently had sex. Syphilis is especially common in Tokyo’s Shinjuku Ward, which is the capital’s primary entertainment and nightlife hub. Syphilis is most common in Japan and expected to rise during the forecast period due to lack of awareness among people.
In addition, the high numbers of HIV and AIDS cases is also expected to create scope for the market growth. In 2016, 1,011 HIV and 437 AIDS cases were reported in Japan. Among the 1,011 HIV cases, 885 were Japanese (857 males; 28 females) and 126 were non-Japanese (108 males; 18 females). Therefore, Japanese males occupied 85% of the total HIV cases and 86% of the total AIDS cases. In 2016, there was no case of congenital infection. Thus, prevalence of such diseases is expected to propel the growth of the Japan STD Diagnostics market.
Research Methodology
The market study of the Japan STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Japan STD Diagnostics Market by Disease Type
5.1.1. Chlamydia
5.1.2. Syphilis
5.1.3. Gonorrhea
5.1.4. Herpes Simplex Virus (HSV)
5.1.5. Human Papilloma Virus (HPV)
5.1.6. Human Immunodeficiency Virus (HIV)
5.1.7. Others
5.2. Japan STD Diagnostics Market by Product
5.2.1. Laboratory Testing Devices
5.2.2. Point-of-Care (POC) Testing Devices
5.3. Japan STD Diagnostics Market by End-user
5.3.1. Hospitals and Clinics
5.3.2. Diagnostic Centers
5.3.3. Homecare
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. AbbVie Inc.
6.3. Becton, Dickinson and Co.
6.4. Biocartis NV
6.5. Bio-Rad Laboratories, Inc.
6.6. Danaher Corp.
6.7. Eli Lilly and Co.
6.8. F. Hoffmann-La Roche Ltd.
6.9. Merck KGaA
6.10. Thermo Fisher Scientific, Inc.
1. JAPAN STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2018-2025 ($ MILLION)
2. JAPAN STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. JAPAN STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. JAPAN STD DIAGNOSTICS MARKET SHARE BY BIOMARKER DISEASE TYPE, 2018 VS 2025 (%)
2. JAPAN STD DIAGNOSTICS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. JAPAN STD DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)